Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/21/23 21:00 | 3/17/23 | EIGR | Health | BioPrd | Biological Products, (No Diag | Mayer Eldon C. III | CA | O | Ex VP,Ch | S | -5 | 1.07 | 0 | -4 | -7 | 56 | D | ||||||||||||||
1/3/23 20:30 | 12/29/22 | EIGR | Health | BioPrd | Biological Products, (No Diag | Murray Christine | CA | D | S | -6 | 1.22 | 0 | -5 | -31 | 11 | D | |||||||||||||||
12/27/22 17:31 | 12/22/22 | EIGR | Health | BioPrd | Biological Products, (No Diag | Dietz Thomas John | CA | D | S | -26 | 1.17 | 0 | -23 | -52 | 21 | D | |||||||||||||||
8/18/22 17:36 | 8/16/22 | EIGR | Health | BioPrd | Biological Products, (No Diag | Apelian David | CA | D | S | -49 | 9.81 | 0 | -5 | -31 | 11 | D | |||||||||||||||
3/14/22 21:22 | 3/14/22 | EIGR | Health | BioPrd | Biological Products, (No Diag | Ryali Sriram | CA | O | CFO | S | -13 | 5.60 | 0 | -2 | -5 | 42 | D | ||||||||||||||
3/14/22 21:21 | 3/14/22 | EIGR | Health | BioPrd | Biological Products, (No Diag | Mayer Eldon C. III | CA | O | Ex VP,Ch | S | -9 | 5.60 | 0 | -2 | -3 | 60 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |